Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | SPHK1 | Q9NYA1 | 7/20 | 0.41 |
| ▸ | SPHK2 | Q9NRA0 | 7/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.33 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.33 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2712146 | 1.00 | EPHX1 (0.50) | EPHX1ALDH1A1SPHK1SPHK2ALOX5 | |
| SCHEMBL28228462 | 1.00 | EPHX1 (0.50) | EPHX1ALDH1A1SPHK1SPHK2ALOX5 | |
| SCHEMBL6470847 | 1.00 | EPHX1 (0.50) | EPHX1ALDH1A1SPHK1SPHK2ALOX5 | |
| SCHEMBL5797801 | 0.95 | EPHX1 (0.48) | EPHX1ALDH1A1SPHK1SPHK2CYP1A2 | |
| SCHEMBL11592604 | 0.92 | EPHX1 (0.43) | EPHX1ALDH1A1SPHK1SPHK2ALOX5 | |
| SCHEMBL9057842 | 0.92 | EPHX1 (0.43) | EPHX1ALDH1A1SPHK1SPHK2ALOX5 | |
| SCHEMBL29459695 | 0.91 | EPHX1 (0.42) | EPHX1ALDH1A1SPHK1SPHK2ALOX5 | |
| SCHEMBL3286073 | 0.91 | EPHX1 (0.42) | EPHX1ALDH1A1SPHK1SPHK2ALOX5 | |
| SCHEMBL28227693 | 0.89 | EPHX1 (0.59) | EPHX1ALDH1A1SPHK1SPHK2ALOX5 | |
| SCHEMBL28227694 | 0.89 | EPHX1 (0.59) | EPHX1ALDH1A1SPHK1SPHK2ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 35731 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4732908-A2 | CANCER TREATMENT USING COMBINATIONS OF ERK AND RAF INHIBITORS | Biomed Valley Discoveries, Inc. (US) | 2026-04-29 | — | — | EP | claimed |
| US-12611398-B2 | Inhalable rapamycin formulation for the treatment of pulmonary hypertension | ORPHAI THERAPEUTICS INC. (US) | 2026-04-28 | — | — | US | claimed |
| US-12605345-B2 | Transdermal drug delivery system | BioPhysics Pharma, Inc. (US) | 2026-04-21 | — | — | US | claimed |
| US-20260062752-A1 | METHODS AND COMPOSITIONS FOR DETECTING AND DIAGNOSING DISEASES AND CONDITIONS | STEALTH BIOTHERAPEUTICS INC. (US) | 2026-03-05 | — | — | US | claimed |
| EP-4698662-A2 | REGULATABLE CONTROLLED EXPRESSION OF A TRANSGENE IN PRIMATES | AskBio Inc. (US) | 2026-02-25 | — | — | EP | claimed |
| EP-4043017-B1 | CANCER TREATMENT USING COMBINATIONS OF ERK AND RAF INHIBITORS | BIOMED VALLEY DISCOVERIES INC (US) | 2026-01-28 | — | — | EP | claimed |
| EP-4680201-A1 | COMPOSITIONS AND USES THEREOF FOR STABILIZATION OF BLOOD SAMPLE COMPONENTS | Streck LLC (US) | 2026-01-21 | — | — | EP | claimed |
| US-12521258-B2 | Anticoagulant compounds and methods and devices for their use | ELIXIR MEDICAL CORPORATION (US) | 2026-01-13 | — | — | US | claimed |
| US-20250388639-A1 | Therapeutic applications based on the inhibition of G Protein-Coupled Receptor 182 (GPR182) | MAX PLANCK GESELLSCHAFT (DE) | 2025-12-25 | — | — | US | claimed |
| US-20250381156-A1 | TREATMENT OR PREVENTION OF CARDIOVASCULAR EVENTS VIA THE ADMINISTRATION OF A COLCHICINE DERIVATIVE | MURRAY AND POOLE ENTPR LTD (GI) | 2025-12-18 | — | — | US | claimed |
| US-4083854-A | 4,5-Didehydro-6-oxo-2-aryl-methoxymethyl-3α-tetrahydropyranacetic acids | THE UPJOHN COMPANY (US) | 1978-04-11 | — | — | US | claimed |
| US-4082776-A | 6-Alkoxy-4α-hydroxy-2β-tetrahydropyranacetic acid γ-lactones | THE UPJOHN COMPANY (US) | 1978-04-04 | — | — | US | claimed |
| US-4070384-A | Process for preparing thromboxane B compounds from prostaglandin fα co | THE UPJOHN COMPANY (US) | 1978-01-24 | — | — | US | claimed |
| US-4054737-A | Thromboxane B analogs | THE UPJOHN COMPANY (US) | 1977-10-18 | — | — | US | claimed |
| US-4052552-A | THROMBOXANE B ANALOGS | THE UPJOHN COMPANY (US) | 1977-10-04 | — | — | US | claimed |
| US-4048194-A | THROMBOXANE B2, PROSTAGLANDINS | THE UPJOHN COMPANY (US) | 1977-09-13 | — | — | US | claimed |
| US-4033949-A | Analogs of thromboxane B2 and processes for their synthesis | THE UPJOHN COMPANY (US) | 1977-07-05 | — | — | US | claimed |
| US-4032542-A | 4α,6-Dihydroxy-5-iodo-2.beta.-aryloxymethyl-3α-tetrahydropyranoacetic acid γ-lactone, 6-alkyl ethers | THE UPJOHN COMPANY (US) | 1977-06-28 | — | — | US | claimed |
| US-4020173-A | 4α,6-Dihydroxy-2β-carboxaldehyde-3α-tetrahydropyranacetic acid γ-lactone, 6-alkyl ethers | THE UPJOHN COMPANY (US) | 1977-04-26 | — | — | US | claimed |
| US-4018804-A | PROSTAGLANDINS AND DERIVATIVES | THE UPJOHN COMPANY (US) | 1977-04-19 | — | — | US | claimed |